ATX Therapeutics is a leading digital health company based in Austin, Texas, that is dedicated to helping individuals manage and prevent chronic diseases such as cancer, heart disease, and COPD. By collaborating with healthcare providers, researchers, health plans, and employers, ATX Therapeutics develops evidence-based digital therapeutic products that promote positive health outcomes and empower patients to make lasting behavior changes. Through a human-centered and data-driven approach, ATX Therapeutics combines clinically-validated interventions with exceptional consumer-grade experiences to deliver sustainable results.

Their innovative solutions engage patients in managing their specific chronic health conditions and associated risk behaviors. The company was founded in 2019 by CEO Adam Falat, who has extensive experience in the digital health industry. Prior to founding ATX Therapeutics, Adam led successful digital health product teams at renowned organizations such as Walgreens and athenahealth.

With a commitment to improving lives and a focus on empowering individuals to live healthier, fuller lives, ATX Therapeutics is at the forefront of revolutionizing the field of digital therapeutics